Cite
HARVARD Citation
Söderlund, S. et al. (n.d.). Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. Leukemia research. pp. 95-103. [Online].